PFS
TEVA icon

Prospera Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$385K Sell
22,945
-665
-3% -$11.1K 0.01% 1008
2025
Q1
$363K Buy
23,610
+280
+1% +$4.3K 0.01% 911
2024
Q4
$514K Sell
23,330
-18,344
-44% -$404K 0.01% 737
2024
Q3
$751K Sell
41,674
-13,975
-25% -$252K 0.02% 589
2024
Q2
$904K Sell
55,649
-20,568
-27% -$334K 0.03% 530
2024
Q1
$1.08M Buy
76,217
+29,307
+62% +$414K 0.03% 476
2023
Q4
$490K Sell
46,910
-1,069
-2% -$11.2K 0.02% 672
2023
Q3
$489K Sell
47,979
-804
-2% -$8.2K 0.02% 620
2023
Q2
$367K Sell
48,783
-46,988
-49% -$354K 0.01% 709
2023
Q1
$848K Buy
95,771
+46,298
+94% +$410K 0.03% 472
2022
Q4
$451K Sell
49,473
-12,337
-20% -$113K 0.02% 563
2022
Q3
$499K Buy
61,810
+27,197
+79% +$220K 0.03% 520
2022
Q2
$260K Sell
34,613
-9,491
-22% -$71.3K 0.01% 665
2022
Q1
$414K Buy
44,104
+16,921
+62% +$159K 0.02% 649
2021
Q4
$218K Sell
27,183
-29,500
-52% -$237K 0.01% 810
2021
Q3
$552K Sell
56,683
-5,147
-8% -$50.1K 0.03% 506
2021
Q2
$612K Sell
61,830
-2,167
-3% -$21.4K 0.03% 478
2021
Q1
$739K Buy
63,997
+20,288
+46% +$234K 0.04% 403
2020
Q4
$422K Buy
43,709
+42,335
+3,081% +$409K 0.03% 448
2020
Q3
$12K Sell
1,374
-43,042
-97% -$376K ﹤0.01% 1072
2020
Q2
$548K Buy
44,416
+2,100
+5% +$25.9K 0.05% 337
2020
Q1
$380K Sell
42,316
-18,223
-30% -$164K 0.04% 362
2019
Q4
$593K Buy
60,539
+19,654
+48% +$193K 0.05% 350
2019
Q3
$281K Buy
40,885
+5,287
+15% +$36.3K 0.03% 450
2019
Q2
$333K Buy
+35,598
New +$333K 0.04% 380
2019
Q1
Sell
-33,518
Closed -$541K 433
2018
Q4
$541K Buy
33,518
+9,152
+38% +$148K 0.11% 182
2018
Q3
$535K Buy
24,366
+8,321
+52% +$183K 0.1% 203
2018
Q2
$385K Buy
+16,045
New +$385K 0.05% 290
2017
Q2
Sell
-7,642
Closed -$245K 455
2017
Q1
$245K Sell
7,642
-144
-2% -$4.62K 0.04% 302
2016
Q4
$286K Buy
+7,786
New +$286K 0.06% 282